Alignment Healthcare, Inc. Common Stock
Here’s whether Alignment Healthcare, Inc. Common Stock (ALHC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.47% over 10 days); strong 1-year return of +66.9%. Concerns: RSI 30 — oversold; 3-month momentum negative (-8.1%); declining volume on rally — weak conviction (0.67x 30d avg). Currently 22.6% off its 52-week high. Score: +2/7.
ALHC is in a confirmed uptrend, trading above both its 50-day ($19.34) and 200-day ($19.31) moving averages. An RSI of 30.0 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +66.9% compares to +16.5% for SPY (beat the market by 50.5%). The current 22.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.